M&As this week: Jaguar Holding Company, Searchlight Pharma

9th June 2016 (Last Updated June 9th, 2016 18:30)

Jaguar Holding Company, a holding company of Pharmaceutical Product Development (PPD), has acquired Synexus Clinical Research from LDC (Managers) for a sale consideration of $258.3m.

Jaguar Holding Company, a holding company of Pharmaceutical Product Development (PPD), has acquired Synexus Clinical Research from LDC (Managers) for a sale consideration of $258.3m.

N M Rothschild & Sons acted as financial advisors, while DLA Piper UK acted as legal advisors for the transaction.

" The acquisition enables Synexus to expand its presence."

The acquisition enables Synexus to expand it presence and achieve substantial growth.

Searchlight Pharma, a pharmaceutical company, plans to expand its business and advance its existing product portfolio of women's health products by acquiring Besins Healthcare Canada.

The acquisition will enable Searchlight Pharma to enhance its activities and presence in women health area and achieve commercial growth across the prescription and non-prescription therapeutics and devices.